Literature DB >> 21315745

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.

Susan B Powell1, Terrence J Sejnowski, M Margarita Behrens.   

Abstract

Oxidative stress, in response to the activation of the superoxide-producing enzyme Nox2, has been implicated in the schizophrenia-like behavioral dysfunction that develops in animals that were subject to either neonatal NMDA receptor-antagonist treatment or social isolation. In both of these animal models of schizophrenia, an environmental insult occurring during the period of active maturation of the fast-spiking parvalbumin-positive (PV+) interneuronal circuit leads to a diminished expression of parvalbumin in GABA-inhibitory neurons when animals reach adulthood. The loss of PV+ interneurons in animal models had been tentatively attributed to the death of these neurons. However, present results show that for the perinatal NMDA-R antagonist model these interneurons are still alive when animals are 5-6 weeks of age even though they have lost their phenotype and no longer express parvalbumin. Alterations in parvalbumin expression and sensory-evoked gamma-oscillatory activity, regulated by PV+ interneurons, are consistently observed in schizophrenia. We propose that cortical networks consisting of faulty PV+ interneurons interacting with pyramidal neurons may be responsible for the aberrant oscillatory activity observed in schizophrenia. Thus, oxidative stress during the maturation window for PV+ interneurons by alteration of normal brain development, leads to the emergence of schizophrenia-like behavioral dysfunctions when subjects reach early adulthood.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315745      PMCID: PMC3106123          DOI: 10.1016/j.neuropharm.2011.01.049

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  163 in total

1.  Prefrontal microcircuits: membrane properties and excitatory input of local, medium, and wide arbor interneurons.

Authors:  L S Krimer; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

Authors:  K Q Do; A H Trabesinger; M Kirsten-Krüger; C J Lauer; U Dydak; D Hell; F Holsboer; P Boesiger; M Cuénod
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

3.  Relations between chemistry and problem-solving among rats raised in enriched and impoverished environments.

Authors:  D KRECH; M R ROSENZWEIG; E L BENNETT
Journal:  J Comp Physiol Psychol       Date:  1962-10

4.  It's about time for thalamocortical circuits.

Authors:  Court Hull; Massimo Scanziani
Journal:  Nat Neurosci       Date:  2007-04       Impact factor: 24.884

5.  GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia.

Authors:  G P Reynolds; C L Beasley
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

Review 6.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

7.  Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood.

Authors:  Daisuke Ibi; Taku Nagai; Hiroyuki Koike; Yuko Kitahara; Hiroyuki Mizoguchi; Minae Niwa; Hanna Jaaro-Peled; Atsumi Nitta; Yukio Yoneda; Toshitaka Nabeshima; Akira Sawa; Kiyofumi Yamada
Journal:  Behav Brain Res       Date:  2009-08-28       Impact factor: 3.332

8.  The development of neural synchrony reflects late maturation and restructuring of functional networks in humans.

Authors:  Peter J Uhlhaas; Frederic Roux; Wolf Singer; Corinna Haenschel; Ruxandra Sireteanu; Eugenio Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

9.  A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Margarita M Behrens; Anthony A Grace
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

10.  Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

Authors:  Stefania Schiavone; Silvia Sorce; Michel Dubois-Dauphin; Vincent Jaquet; Marilena Colaianna; Margherita Zotti; Vincenzo Cuomo; Luigia Trabace; Karl-Heinz Krause
Journal:  Biol Psychiatry       Date:  2009-06-26       Impact factor: 13.382

View more
  75 in total

Review 1.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

2.  Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons.

Authors:  Nadezhda V Povysheva; Jon W Johnson
Journal:  J Neurophysiol       Date:  2012-01-11       Impact factor: 2.714

Review 3.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

Review 4.  How animal models inform child and adolescent psychiatry.

Authors:  Hanna E Stevens; Flora M Vaccarino
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-02-12       Impact factor: 8.829

5.  Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction.

Authors:  Aarron Phensy; Kathy L Lindquist; Karen A Lindquist; Dania Bairuty; Esha Gauba; Lan Guo; Jing Tian; Heng Du; Sven Kroener
Journal:  J Neurosci       Date:  2020-06-30       Impact factor: 6.167

6.  Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.

Authors:  Toshihiro Nomura; Yoshihiro Oyamada; Herman B Fernandes; Christine L Remmers; Jian Xu; Herbert Y Meltzer; Anis Contractor
Journal:  Neuropharmacology       Date:  2015-04-30       Impact factor: 5.250

Review 7.  Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.

Authors:  Hirofumi Morishita; Marija Kundakovic; Lucy Bicks; Amanda Mitchell; Schahram Akbarian
Journal:  Neurobiol Learn Mem       Date:  2015-04-04       Impact factor: 2.877

Review 8.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

9.  Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1.

Authors:  Nevena V Radonjić; Igor Jakovcevski; Vladimir Bumbaširević; Nataša D Petronijević
Journal:  Psychopharmacology (Berl)       Date:  2013-02-05       Impact factor: 4.530

Review 10.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.